Tresiba FlexTouch Pens

Tresiba Flextouch is a long-acting insulin prescribed for managing blood sugar levels in individuals with diabetes. With its innovative prefilled pen design, Tresiba Flextouch simplifies insulin administration, offering convenience and consistent blood sugar control for both type 1 and type 2 diabetes patients.

Benefits:

• Provides up to 42 hours of blood sugar control with once-daily dosing.
• Reduces the risk of hypoglycemia, especially at night.
• It offers flexibility in dosing time, making it ideal for busy lifestyles.
• A prefilled and ready-to-use pen ensures precise and easy administration.
• Suitable for adults and children as young as one-year-old.

Dosage:

• The initial dose should be individualized based on blood glucose monitoring results and patient needs.
• Inject subcutaneously once daily at any time of day. Rotate injection sites between the abdomen, thigh, or upper arm.
• Adjust the dose based on blood glucose monitoring and glycemic control goals.
• If a dose is missed, take it as soon as remembered, ensuring at least 8 hours have passed since the last dose.
  

Warnings and Precautions:

• Monitor for signs of hypoglycemia, such as dizziness, shakiness, or sweating. Adjust the dose if necessary and increase blood glucose monitoring.
• Severe, life-threatening allergic reactions can occur. Discontinue use and seek medical attention if symptoms appear.
• Always check insulin labels before administration to avoid accidental mix-ups.
• Use caution if taking certain medications, as fluid retention and heart failure may occur. Monitor for signs and symptoms.
• Monitor potassium levels in patients at risk for hypokalemia and treat if necessary.

Usage Instructions:

• Administer once daily, preferably at the same time each day, unless directed otherwise by a healthcare provider.
• Prime the pen before each use to ensure the correct insulin dose is delivered.
• Rotate injection sites between the abdomen, thigh, or upper arm to avoid irritation.
• Follow your healthcare provider’s specific dosage and usage recommendations.
  

Storage Information:

• Store unopened pens in the refrigerator between 36°F and 46°F (2°C to 8°C).
• After first use, keep the pen at room temperature (below 86°F or 30°C) and use it within 8 weeks.
• Protect from direct sunlight and heat, and do not freeze.
  

Common Side Effects:

• Hypoglycemia (low blood sugar) is characterized by dizziness, shakiness, or sweating.
• Injection site reactions, such as redness, itching, or swelling.
• Mild weight gain, familiar with insulin therapy.
• Consult a healthcare professional if severe side effects or allergic reactions occur.

More information about Tresiba

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide